Can i take metformin and jardiance together?

Yes. Metformin and Jardiance (empagliflozin) are commonly used together for type 2 diabetes. Using them in combination is designed to improve blood sugar control by working through different mechanisms.

Can both be taken at the same time?
There’s no general rule against taking metformin and Jardiance together. They are often prescribed as a combination because metformin reduces glucose production in the liver, while Jardiance helps the kidneys remove glucose through urine.

What to watch for when combining them
Even though the combination is widely used, safety depends on your individual situation:

- Dehydration and low blood pressure risk: Jardiance can increase urination. If you already get lightheaded, have low blood pressure, or are prone to dehydration, your clinician may adjust doses or monitor you more closely.
- Kidney function: Jardiance depends on kidney function for safe use and for effectiveness. Your prescriber typically checks labs (creatinine/eGFR) before and during treatment.
- Low blood sugar: Metformin alone rarely causes hypoglycemia. Jardiance also has a low risk of hypoglycemia by itself, but the risk can rise if you take it with insulin or sulfonylureas (like glipizide).
- Genital yeast infections and urinary tract infections: These are known side effects of SGLT2 inhibitors like Jardiance. Keeping good hygiene and watching for symptoms matters.

When you should ask your prescriber before starting or continuing
- If you are frequently ill, have vomiting/diarrhea, or are not eating well (risk of dehydration).
- If you have a history of recurrent genital infections or urinary infections.
- If you have reduced kidney function.
- If you take insulin or a sulfonylurea and want to reduce hypoglycemia risk.

If you want, tell me the doses you have for metformin and Jardiance and what other diabetes medications you take (including insulin or sulfonylureas), and I can help you understand the typical way they’re used and what safety issues to confirm with your clinician.

Sources:
1. https://www.drugpatentwatch.com